The purpose of this study is to provide safety and efficacy data for the X-Suit NIR® Covered Biliary Metallic Stent for subjects with malignant stricture(s) in the biliary tree. The study is designed to support the regulatory requirement of a 510(k) marketing application in the United States.
This is a non-randomized, multi-center, prospective, single arm clinical study of the X-Suit NIR® Covered Biliary Metallic Stent for the palliation of malignant strictures in the biliary tree via endoscopic approach. Adult males and females (≥ 18 years old), with clinical symptoms of biliary obstruction and inoperable extrahepatic biliary obstruction by any malignant process. The expected duration of this study is approximately 18 months from the time of first subject enrollment to the time of the last subject's 6-month post stent implantation follow-up visit.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
68
Hôpital Erasme Brussels (ULB)
Brussels, Belgium
Hillel Yafeh Medical Center
Hadera, Israel
Rambam Medical Center
Haifa, Israel
Shaare Zedek Medical Center
Jerusalem, Israel
Maintenance of a total serum bilirubin level ≤ 3.0 mg/dL or a reduction of >30% if baseline value was greater than 3.0 mg/dL
Maintenance of a total serum bilirubin level ≤ 3.0 mg/dL or a reduction of \>30% if baseline value was greater than 3.0 mg/dL- outcome
Time frame: 6 months follow up or prior to death, whichever comes first
total number of adverse events
total number of adverse events (anticipated and unanticipated)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Haddasah Medical Center
Jerusalem, Israel
Sheba Medical Center, Tel Hashomer
Ramat Gan, Israel
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
University Medical Center Utrecht
Utrecht, Heidelberglaan, Netherlands
Academic Medical Center (AMC)
Amsterdam, Netherlands